| P2093 | author name string | Timothy Peters-Strickland | |
| | Mirza Rahman | |
| | Imad Al-Dakkak | |
| | Wally Landsberg | |
| | Emiel van Heumen | |
| | Antonia Coppin-Renz | |
| | Uli Geis | |
| P2860 | cites work | Risk minimization activities of centrally authorized products in the EU: a descriptive study | Q83459676 |
| | Bipolar disorder in children | Q21284506 |
| | The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review | Q26748677 |
| | Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial | Q34586878 |
| | A systematic review of the frequency and severity of manic symptoms reported in studies that compare phenomenology across children, adolescents and adults with bipolar disorders | Q37622008 |
| | Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder. | Q37733456 |
| | Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents | Q37967965 |
| | Impact of regulatory guidances and drug regulation on risk minimization interventions in drug safety: a systematic review | Q38019025 |
| | Post-approval evaluation of effectiveness of risk minimisation: methods, challenges and interpretation | Q38172854 |
| | Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives | Q38388540 |
| | Systematic review of the prevalence of bipolar disorder and bipolar spectrum disorders in population-based studies | Q38448900 |
| | Patterns of Antipsychotic Prescribing by Physicians to Young Children | Q39600765 |
| | An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. | Q40176997 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P304 | page(s) | 797-806 | |
| P577 | publication date | 2018-08-01 | |
| P1433 | published in | Drug Safety | Q15724462 |
| P1476 | title | Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study | |
| P478 | volume | 41 | |